Stock Earnings Inozyme Pharma Inc (INZY) receives a Buy rating from Jefferies Inozyme Pharma Inc’s recently made public that its CEO Treco Douglas A unloaded Company’s shares for reported $52210.0 on Apr
Analysts Viewpoint Inozyme Pharma Inc [INZY] Shares Fall Approximately -24.70% Over the Year Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Inozyme Pharma
Insiders Updates Inozyme Pharma Inc [INZY] CEO makes an insider purchase of 7,523 shares worth 52210.0. Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Inozyme Pharma
Analysts Viewpoint Inozyme Pharma Inc [INZY] Shares Fall Approximately -11.38% Over the Year Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Inozyme Pharma